Local tolerance and PK/PD assessment of TAR-0520 gel when applied topically in healthy subjects

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504178-39-00

Acronym

TAR006

Enrollment

Registered

2023-10-23

Start date

2023-11-09

Completion date

Unknown

Last updated

2023-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of anticancer therapy adverse reactions

None listed

Sex/Gender

All

Age

18 Years to 64 Years

France

None listed

Source: EU CTIS · Data processed: Jun 13, 2026